ORIC Pharmaceuticals (ORIC) Stock Chart & Stock Price History $7.64 -0.39 (-4.86%) Closing price 04:00 PM EasternExtended Trading$7.80 +0.16 (+2.03%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ORIC Pharmaceuticals Stock Price Performance 5 Day Performance-3.54%1 Month Performance-21.12%3 Month Performance-16.60%6 Month Performance-20.50%Year-To-Date Performance-0.79%1 Year Performance-45.39% Receive ORIC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ORIC Stock Chart for Monday, March, 3, 2025 ORIC Chart by TradingView ORIC Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/28/2025$7.84$8.03+2.42%$8.07$7.56664,789 shs$570.35 million02/27/2025$8.30$7.84-5.54%$8.59$7.82947,199 shs$556.85 million02/26/2025$8.08$8.30+2.72%$9.53$8.101.97 million shs$589.52 million02/25/2025$7.56$8.08+6.88%$8.12$7.42816,006 shs$573.90 million02/24/2025$7.68$7.56-1.56%$7.86$7.45582,213 shs$536.99 million02/21/2025$7.47$7.68+2.81%$8.09$7.441.06 million shs$545.49 million02/20/2025$7.94$7.47-5.92%$7.98$7.341.19 million shs$527.16 million02/19/2025$7.85$7.94+1.15%$8.57$7.681.88 million shs$560.33 million02/18/2025$8.36$7.85-6.10%$8.80$7.481.44 million shs$553.97 million02/17/2025$8.36$8.36$9.20$7.902.85 million shs$589.97 million Get the Latest News and Ratings for ORIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/14/2025$8.27$8.36+1.09%$9.20$7.902.85 million shs$589.97 million02/13/2025$9.45$8.27-12.49%$9.64$7.491.89 million shs$583.61 million02/12/2025$9.85$9.45-4.06%$9.69$8.731.11 million shs$666.89 million02/11/2025$11.23$9.85-12.29%$11.72$7.873.82 million shs$695.11 million02/10/2025$12.25$11.23-8.33%$14.67$10.975.73 million shs$792.50 million02/07/2025$12.54$12.25-2.31%$13.00$11.87882,467 shs$864.48 million02/06/2025$12.39$12.54+1.21%$13.30$12.361.60 million shs$884.95 million02/05/2025$10.75$12.39+15.26%$12.62$10.741.03 million shs$874.36 million02/04/2025$10.15$10.75+5.91%$12.01$10.181.61 million shs$758.63 million02/03/2025$10.42$10.15-2.59%$10.59$9.951.14 million shs$716.29 million Related Companies Protagonist Therapeutics Stock Chart Centessa Pharmaceuticals Stock Chart Mesoblast Stock Chart CG Oncology Stock Chart Agios Pharmaceuticals Stock Chart Harmony Biosciences Stock Chart IDEAYA Biosciences Stock Chart Belite Bio Stock Chart Janux Therapeutics Stock Chart Galapagos Stock Chart Receive ORIC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORIC) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ORIC Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
